RxDoctor Payments DataLook up a doctor →

Sarah Andrews, DO

Internal Medicine · Tulsa, OKNPI 1912228149

Payments from drug & device makers

$10,878in general payments, 2019–2025

Across 630 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Pfizer$1K
  • Lilly USA, LLC$862
  • Amgen$565
  • plus $5K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)88$1,332
Novo Nordisk85$1,289
AstraZeneca51$1,134
Pfizer67$1,125
Lilly USA, LLC53$862
Amgen(2 entities)32$565
Boehringer Ingelheim28$396
GSK22$354
Teva Pharmaceuticals USA, Inc.17$343
Takeda Pharmaceuticals U.S.A., Inc.19$334
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$268
Johnson & Johnson15$262
Sanofi-aventis U.S. LLC11$197
Axsome Therapeutics, Inc.8$190
Abbott10$178
Idorsia Pharmaceuticals US Inc9$175
Astellas Pharma US Inc9$157
Exact Sciences10$153
Madrigal Pharmaceuticals1$119
Lundbeck LLC4$105
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$100
Sumitomo Pharma America, Inc.4$97
Eisai Inc.4$88
Otsuka America Pharmaceutical, Inc.4$84
Kowa Pharmaceuticals America, Inc.5$77
Novartis3$71
Esperion Therapeutics, Inc.3$61
Nalpropion Pharmaceuticals LLC4$57
Merck3$53
Dexcom, Inc.3$49
E.r. Squibb & Sons, L.L.C.3$45
Ironwood Pharmaceuticals, Inc3$43
Bayer3$42
Biohaven Pharmaceutical Holding Company Ltd.2$39
Shire North American Group Inc3$39
Antares Pharma, Inc.2$36
Amarin Pharma, Inc.2$34
Intra-sana Laboratories2$31
Irhythm Technologies, Inc.2$31
Hikma Pharmaceuticals USA2$29
Lexicon Pharmaceuticals, Inc.1$29
Adlon Therapeutics L.p.2$27
Vanda Pharmaceuticals Inc.1$26
Collegium Pharmaceutical, Inc.1$23
Mylan Specialty L.p.1$22
Radius Health, Inc.1$17
Inspire Medical Systems, Inc.1$16
Currax Pharmaceuticals LLC1$15
Shionogi Inc1$15
Therapeuticsmd, Inc.1$14
Aytu Biopharma, Inc.1$12
Zyla Life Sciences, Inc.1$12
Phathom Pharmaceuticals, Inc.2$8

How this compares

$10,878 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$101,693
Medicare patients
286
Services billed
5,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Tulsa

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →